Bold Therapeutics Secures Funding to Prepare BOLD-100 for COVID-19 Clinical Trials
VANCOUVER, BC, Jan. 6, 2021 |PRNewswire| -- Bold Therapeutics, a clinical-stage biopharmaceutical company developing BOLD-100, is pleased to announce that it is one of only four companies selected to receive advisory services and research and development funding from the National Research…
Bold Therapeutics Secures Funding to Prepare BOLD-100 for COVID-19 Clinical Trials
VANCOUVER, BC, Jan. 6, 2021 |PRNewswire| -- Bold Therapeutics, a clinical-stage biopharmaceutical company developing BOLD-100, is pleased to announce that it is one of only four companies selected to receive advisory services and research and development funding from the National Research…